FDA Approves Buprenorphine Implant

March 27, 2013 - Less than a minute read

On March 21st the FDA approved a subdermal implant for Buprenorphine. Buprenhorphine is rapidly becoming the standard in opiate addiction treatment, as an alternative to methadone. The implant could be a large step forward in the control of opiate addiction. For more information read this full article at Medscape News.